MIBG Therapy for Pheochromocytomas and Paragangliomas
2 Bekeken
• 07/02/23
0
0
insluiten
administrator
abonnees
Dr. David Mankoff discusses meta-Iodobenzylguanidine (MIBG) therapy, which is a highly targeted therapy for treatment of pheochromocytomas and paragangliomas, at the 2012 Focus on Neuroendocrine Tumors Conference.
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties